Method details {#sec0005}
==============

Many different types of pollutants have been found in environmental compartments as water. Licit and illicit drugs or personal care products are some of the so-called emerging contaminants extensively used by humans [@bib0005], [@bib0010]. A number of analytical methods are already available [@bib0015], [@bib0020], [@bib0025], [@bib0030], [@bib0035], [@bib0040], [@bib0045] to determine emerging contaminants in environmental matrices at low concentrations. However, these methods are only reported for one type of instrument. In this study, we proposed a procedure to analyse pharmaceuticals, illicit drugs, personal care products and others contaminants on different water matrices through a common method for a triple quadrupole (QqQ) and a quadrupole time-of-flight (QqTOF) mass spectrometers.

Reagents and materials {#sec0010}
----------------------

Acetaminophen, bezafibrate, bisphenol A, butylparaben, chloramphenicol, clofibric acid, diclofenac, ethylparaben, flufenamic acid, gemfibrozil, ibuprofen, indomethacin, methylparaben, naproxen, propylparaben, salicylic acid, thiamphenicol, triclocarban, triclosan and warfarin from Sigma-Aldrich (The Woodlands,Texas, USA) and tetrahydrocannabinol (THC) and 11-nor-9-carboxy-\<DELTA\>9-tetrahydrocannabinol (THC-COOH) from LoGiCal (Luckenwalde, Germany) were used as target analytes for QqQ analysis. Calibration standards were prepared by serial dilution of the mixed working solution. Stock and working solutions were stored at −20 °C in the dark [@bib0050].

Water used for preparation of calibration standards and LC--MS mobile phase was purified by an Elix Milli-Q system (Millipore, Billerica, MA, USA). Methanol was purchased from Panreac (Castellar del Vallès, Barcelona, Spain) and formic acid was purchased from Amresco (Solon, OH, USA). Ammonium fluoride was acquired from Alfa Aesar GmbH & Co KG (Karlsruhe, Germany).

Extraction procedure {#sec0015}
--------------------

(1)Vacuum filter the samples (250 mL) through 0.45 μm retention capacity glass fiber filter of 90 mm diameter by Advantec (Toyo Roshi Kaisha, Ltd., Japan) using a Bücher funnel (with the filter) over a 250 mL Kitasato flask with 400 mbar h^−1^ Pa^−1^ of vacuum, to remove solid particles before the solid phase extraction (SPE).(2)Put the Phenomenex Strata-X 33u Polymeric Reversed Phase (200 mg/6 mL) cartridges (Phenomenex, Torrance, Ca, USA) into a 12 port vacuum manifold Supelco Visiprep 57030-U of Sigma-Aldrich (St. Louis, MO, EEUU).(3)Condition the cartridge with 6 mL methanol and 6 mL of Milli-Q water both with 400 mba h^−1^ Pa^−1^ vacuum.(4)Pass the samples through the cartridges under previous vacuum at a flow rate of 10 mL min^−1^.(5)Wash the cartridges with 6 mL of Milli-Q water.(6)Dry the cartridges under vacuum for 15 min.(7)Elute the analytes on a 15 mL Falcon tube VWR (Radnor, PA, USA) with 6 mL of methanol and then 3 mL of a methanol--dichloromethane solution (1:1, v/v) at gravity flow.(8)Evaporate the extracts to dryness at 40 °C using a combined sample concentrator model SBHCONC/1 and a heating plate model SBH130D/3 both manufactured by Stuart^®^ (Stafford, UK).(9)Redissolve the residue in 1 mL of water-methanol (70:30, v/v) by agitation and ultrasonication for 1 min and pass the extract to 2 mL amber vials with stoppers 99 mm + Septum Sil/PTFE, both manufactured by Análisis Vínicos S.L. (Tomelloso, Spain).

UHPLC-QqTOF-MS/MS conditions {#sec0020}
----------------------------

The chromatography was performed with an Agilent 1260 Infinity (Agilent, Waldbronn, Germany) using an Agilent Poroshell EC-C18 maintained at temperature of 30 °C. A constant flow rate of 0.2 mL min^−1^ was used. The mobile phase consists of two solvents, 2.5 mM ammonium fluoride in methanol (as organic solvent) and 2.5 mM ammonium fluoride in water (as aqueous solvent). The UHPLC system was coupled to a hybrid QqTOF ABSciex Triple TOF™ 5600 (Framingham, MA, USA). The MS acquisition was performed using negative ionization (NI) and scan mass spectra between *m*/*z* 100--700 with the Turbo Ionspray source. The MS parameters were: ion spray voltage, 5000 V; declustering potential (DP), 120 V; collision energy (CE), 10; temperature 400 °C with curtain gas (CUR) 25 (arbitrary units); ion source gas 1 (GS1) 50 and ion source gas 2 (GS2) 50. The QqTOF-MS/MS instrument was calibrated after every three samples using external reference compounds. The MS/MS acquisition was also performed using information-dependent acquisition (IDA) following operating parameters: declustering potential two (DP2), 110 V; ion release delay (IRD), 67 V; ion release width (IRW), 25 V; IDA MS/MS was performed at a fixed CE of 40 V, ions that exceeded 100 cps and ion tolerance of 50 mDa (isotopes higher than 4 Da were excluded). Data acquisition and processing was carried out using software Analyst (Framingham, MA, USA), Peak View 1.0 with the application XIC manager and MultiQuant 2.0.

Sampling {#sec0025}
--------

The developed method was applied to 21 influent and 21 effluent samples collected from three wastewater treatment plants (WWTPs) of metropolitan area of Valencia and 25 surface waters from Túria River. Wastewater samples were 24-h composite samples and river samples were grab ones. All samples were stored in polyethylene terephthalate (PET) bottles and once arrived at the laboratory, immediately frozen at −20 °C until analysis to prevent degradation of contaminants.

Validation of the analytical method {#sec0030}
-----------------------------------

Validation of the analytical method was performed partly according to the Commission Decision 2002/657/EC [@bib0055] and partly to the Eurachem guide [@bib0060] on that subject since none of them has a binding nature for water contaminants.

[Table 1](#tbl0005){ref-type="table"} shows limit of quantification (LOQ), matrix effect (ME), recovery and relative standard deviation (RSD) obtained by UHPLC-QqTOF determination. The method provides LOQ between 1 and 150 ng L^−1^, recoveries from 39% to 115%, matrix effects ranged from 6 to −52% and relative standard deviations (RSD) lower than 21%. The linearity was determined by calibration curves from LOQ- 5000 ng L^−1^ in water-methanol (70:30) or as a matrix matched standards, with linear coefficients of determination (R^2^) ≥ 0.99, except for salicylic acid (R^2^) ≥ 0.98. Table **S1** in Supplementary information depicts these parameters for UHPLC-QqQ.

[Table 2](#tbl0010){ref-type="table"} shows the quantification of the selected analytes in the different water samples, as mean value ± RSD using QqQ and QqTOF instruments. The quantification of the detected compounds in the three matrices with QqQ was carried out according to the instrumental conditions previously reported [@bib0005] (see Table **S2** in Supplementary information). The quantification of detected compounds with QqTOF was performed using MultiQuant 2.0 software. The results of QqQ and QqTOF were very similar, which confirms that the method is valid for both.

[Table 3](#tbl0015){ref-type="table"} presents, mass (Da), adduct, extraction mass (Da), mass error (ppm), retention time (RT) and intensity of the selected compounds (spiked Milli-Q water with 100 ng L^−1^). The identification of target and non-target was carried out against the XIC manager Table with data of 1212 pharmaceuticals, 546 pesticides, 378 polyphenols and 233 mycotoxins. Furthermore, a total of 86 ± 9 pharmaceuticals, 2 ± 1 pesticides and 14 ± 3 other compounds were detected in influent samples; 45 ± 14 pharmaceuticals, 1 ± 1 pesticides and 7 ± 3 other compounds were detected in effluent samples, and 20 ± 6 pharmaceuticals, 1 ± 1 pesticides and 5 ± 3 other compounds in river water samples. [Fig. 1](#fig0005){ref-type="fig"} illustrates the identification of acetaminophen (paracetamol) and [Fig. 2](#fig0010){ref-type="fig"} of the non-selected hydrochlorothiazide to show the identification system capabilities. Fig. **S1** in Supplementary information shows the extracted ion chromatogram of all substances present in water and the non-target compound identification of theophylline in influent wastewater sample.

Additional information {#sec0035}
======================

Background {#sec0040}
----------

There are hundreds, even thousands of emerging contaminants that can occur in water. Traditionally, the scheme used for their determination involves generic sample preparation procedures able to extract almost any of them, and target determination for the unique and highly specific detection of the selected contaminant(s) [@bib0015], [@bib0020], [@bib0025]. This scheme is time-consuming (ca. 30 min each chromatographic run for a specific group of contaminants) and do not have versatility to detect unexpected emerging contaminants not selected for the target analysis. Currently, there are some reports of non-target detection through high resolution mass spectrometry that provide full scan information as well as compound fragmentation (any *m*/*z* signal from the sample extract) [@bib0010], [@bib0040]. However, high resolution mass spectrometer can provide inaccurate quantification [@bib0040] or enough sensitivity [@bib0010]. Latest generation instruments have improved their quantification possibilities as well as the identification capabilities of any unexpected substance by the application information dependent acquisition (IDA) modes that automatically provide MS/MS spectra of the most intense precursor ions (without previous selection) as an additional confirmation of the detected compounds [@bib0010].

The few examples of these broad screening systems are mostly focus on the positive ionization mode because there are more contaminants that ionized in positive mode and their MS sensitivity is higher. When mass spectrometry is combined with liquid chromatography (recommended for polar compounds as the emerging contaminants) the commonly used additives of the mobile phases (volatile salts and acids) enhanced the ionization in the positive ionization mode and inhibited it in the negative ionization one. Acidic contaminants, commonly better ionized by negative ionization are more difficult to detect and frequently the sensitivity does not reach the low levels emerging contaminants are present in water. Recently, Petrie et al. [@bib0045] demonstrated a substantial improvement of ionization efficiency in negative ionization mode by using NH~4~F enriched mobile phase to metabolomics studies. Our previously reported method using NH~4~F as mobile phase additive instead of more conventional substances also improved the ionization efficiency of the 21 selected compounds in a reproducible way using a triple quad instrument [@bib0005]. These results were recently confirmed for wide range of compounds [@bib0050]. Our current study proves that the addition of NH~4~F to the mobile phase instead of more conventional ammonium formate is also successful for the simultaneous determination of acidic contaminants in water by UHPLC-QqTOF [@bib0065], [@bib0070] increasing sensitivity and quantification capabilities. The strong basicity of the fluoride anion (F^−^) in the gas phase increases deprotonation of basic analytes.

The results showed good agreement between both systems for the analysed samples. For QqQ, naproxen was the pharmaceutical at highest concentration (3327 ng L^−1^) at the influent of the WWTPs which was in a lower concentration at the effluent (10 ng L^−1^). Indomethacin, clofibric acid and triclocarban were the lowest detected with 7 ng L^−1^ in influent samples. Regarding effluent samples, the highest detected concentration was diclofenac with 173 ng L^−1^, being the gemfibrozil the compound with the lowest (5 ng L^−1^). Finally, for river waters, the concentration of target analytes was, in general, lower than WWTPs samples being the compound in major concentration the acetaminophen with 177 ng L^−1^ and ibuprofen with 153 ng L^−1^. Concerning the concentration calculated with QqTOF, the mean concentration levels detected in influent samples ranged from 12 ng L^−1^ (clofibric acid) to 2963 ng L^−1^ (naproxen) being naproxen the most detected compound as in the case of QqQ. In the effluent the highest concentrations were methylparaben (121 ng L^−1^) followed by diclofenac (109 ng L^−1^). In river waters the concentration levels ranged from 7 ng L^−1^ (butylparaben) to 159 ng L^−1^ (ibuprofen). These results show a good correlation between both techniques as in our previous paper [@bib0015].

Appendix A. Supplementary data {#sec0050}
==============================
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![MS and MS/MS Spectra of target analyte acetaminophen (paracetamol).](gr1){#fig0005}

![MS and MS/MS Spectra of non-target analyte hydrochlorothiazide.](gr2){#fig0010}

###### 

Method performance parameters: limit of quantification (LOQ, ng L^−1^), absolute recoveries (%), method repeatability (RSD, %) and matrix effect (ME, %) using QqTOF for effluent, influent and river water samples.

Table 1

  Analyte           WWTP Influent   WWTP Effluent   River water                                                
  ----------------- --------------- --------------- ------------- ----- ----- ----- ---- ----- ---- ----- ---- -----
  Acetaminophen     30              84              15            −33   15    86    14   −26   15   95    10   −12
  Bezafibrate       30              75              15            −32   20    78    13   −28   10   85    11   −16
  Bisphenol A       20              80              19            −12   10    80    12   −10   5    89    17   −18
  Butylparaben      10              79              17            −19   5     101   18   −19   5    115   12   −10
  Chloramphenicol   50              62              11            −36   20    75    17   −32   20   92    10   −23
  Clofibric acid    100             61              12            −41   30    70    21   −31   20   76    20   −31
  Diclofenac        150             82              10            −47   40    91    15   −45   30   98    12   −15
  Ethylparaben      50              81              13            −31   25    95    11   −35   20   96    18   −28
  Flufenamic acid   40              71              14            −29   30    69    15   −18   5    89    15   −16
  Gemfibrozil       10              61              9             −29   10    67    12   −20   10   78    17   −9
  Ibuprofen         100             80              11            −32   80    92    18   −15   50   90    12   −11
  Indomethacin      50              78              15            −15   50    98    10   −11   30   79    13   −2
  Methylparaben     30              80              9             −33   10    90    12   −35   5    89    20   −19
  Naproxen          50              71              17            −30   20    85    18   −32   30   89    17   −21
  Propylparaben     50              71              21            −31   5     81    13   −24   10   102   13   −5
  Salicylic Acid    100             39              10            −52   50    62    18   −39   20   61    25   −13
  THC               50              48              18            −9    20    52    17   −10   10   54    19   −6
  THC-COOH          10              50              9             −19   10    63    14   −19   5    62    15   6
  Thiamphenicol     120             74              11            −21   100   92    19   −20   80   89    18   −7
  Triclocarban      50              85              13            −19   5     79    15   −21   5    91    14   5
  Triclosan         20              82              19            −10   20    91    15   2     10   76    15   −12
  Warfarin          30              73              8             −11   20    84    12   −22   1    86    13   −13

Linearity: linear coefficients (R^2^) were ≥ 0.99 in all cases, except for salicylic acid (R^2^ ≥ 0.98); LOQ was established as the concentration that, after extraction, gives a UHPLC peak height value 1.0 × 10^4^; Recoveries and relative standard deviations (RSDs) of selected compounds were calculated in samples spiked at 100 ng L^−1^ subtracting the peak areas corresponding to native analytes in the sample and tested in quintuplicate; Matrix effect was evaluated by comparing the slope of the calibration curves obtained for spiked influent, effluent or surface water extracts with the slope of that obtained for standard prepared in water-methanol (70:30, v/v) spiked at the same level.

###### 

Comparison of the quantitative results obtained using the ABSciex TripleTOF™ 5600 (QqTOF) and a more traditional triple quadrupole (QqQ) for influent, effluent and river water samples.

Table 2

  Compounds[a](#tblfn0005){ref-type="table-fn"}   Sample 1 Influent (ng L^−1^)[b](#tblfn0010){ref-type="table-fn"}   Sample 2 Effluent (ng L^−1^)[b](#tblfn0010){ref-type="table-fn"}   Sample 3 River Water (ng L^−1^)[b](#tblfn0010){ref-type="table-fn"}                 
  ----------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------ --------------------------------------------------------------------- ------ ------ ------
  Acetaminophen                                   2114                                                               2497                                                               31                                                                    21     139    177
  Bezafibrate                                     35                                                                 47                                                                 11                                                                    15     12     7
  Bisphenol A                                     495                                                                571                                                                96                                                                    72     36     41
  Butylparaben                                    35                                                                 22                                                                 n.d.                                                                  n.d.   7      5
  Chloroamphenicol                                n.d.                                                               n.d.                                                               n.d.                                                                  n.d.   62     68
  Clofibric acid                                  12                                                                 7                                                                  n.d.                                                                  n.d.   n.d.   n.d.
  Diclofenac                                      296                                                                331                                                                109                                                                   173    39     33
  Ethylparaben                                    99                                                                 113                                                                49                                                                    71     n.d.   6
  Flufenamic acid                                 75                                                                 90                                                                 39                                                                    48     29     22
  Gemfibrozil                                     105                                                                155                                                                n.d.                                                                  5      31     34
  Ibuprofen                                       1796                                                               1978                                                               n.d.                                                                  n.d.   159    153
  Indomethacin                                    n.d.                                                               7                                                                  n.d.                                                                  18     n.d.   n.d.
  Methylparaben                                   259                                                                331                                                                121                                                                   99     19     24
  Naproxen                                        2963                                                               3327                                                               21                                                                    10     38     36
  Propylparaben                                   494                                                                519                                                                36                                                                    45     11     12
  Salicylic acid                                  596                                                                778                                                                n.d.                                                                  n.d.   29     22
  THC                                             n.d.                                                               n.d                                                                n.d.                                                                  n.d.   n.d.   n.d.
  THC-COOH                                        409                                                                592                                                                n.d.                                                                  n.d.   21     23
  Thiamphenicol                                   n.d.                                                               n.d.                                                               n.d.                                                                  n.d.   n.d.   10
  Triclocarban                                    n.d.                                                               7                                                                  n.d.                                                                  n.d.   n.d.   n.d.
  Triclosan                                       752                                                                926                                                                n.d                                                                   n.d.   n.d.   n.d.
  Warfarin                                        n.d.                                                               11                                                                 29                                                                    31     33     54

n.d.: non-detected.

Only analytes that occur in any of the samples.

Average (SD) n = 3.

###### 

Experimental parameters used for the identification of the target analytes (n = 5).

Table 3

  Name              Mass (Da)   Adduct   Extraction Mass (Da)   Found at mass (Da)   Error ppm   Error (mDa)   Found at RT (min)   Intensity
  ----------------- ----------- -------- ---------------------- -------------------- ----------- ------------- ------------------- -----------
  Acetaminophen     151.06333   −H       150.05605              150.05612            0.4         0.3           1.12                35326
  Bezafibrate       361.10809   −H       360.10427              360.10409            −0.8        −0.2          14.36               40634
  Bisphenol A       228.11504   −H       227.11496              227.11431            −2          −0.7          14.86               73687
  Butylparaben      194.09430   −H       193.09421              193.09438            0.8         0.2           13.31               70035
  Chloramphenicol   322.01233   −H       321.01129              321.01174            1.2         0.4           10.38               63257
  Clofibric acid    214.03967   −H       213.03037              213.02899            −4.2        −1.4          9.89                55963
  Diclofenac        295.01669   −H       294.01596              294.01617            0.6         0.2           15.87               75981
  Ethylparaben      166.06299   −H       165.06196              165.06323            3.3         1.3           12.36               62257
  Flufenamic acid   281.06636   −H       280.05909              280.05942            1.2         0.3           14.63               45704
  Gemfibrozil       250.15689   −H       249.14962              249.1498             0.7         0.2           14.59               64434
  Ibuprofen         206.13068   −H       205.1234               205.12357            0.8         0.2           14.52               70035
  Indomethacin      357.07678   −H       356.07536              356.07640            2.9         2.9           16.25               59363
  Methylparaben     152.04735   −H       151.04631              151.04657            0.9         0.9           9.64                61259
  Naproxen          230.09430   −H       229.09411              229.09489            2.6         2.6           13.91               79632
  Propylparaben     180.07864   −H       179.07796              179.07803            0.4         0.4           14.47               42963
  Salicylic acid    138.03169   −H       137.03165              137.03172            0.4         0.4           2.56                49332
  THC               314.22458   −H       313.2173               313.21728            −0.1        0             16.11               44379
  THC-COOH          344.19876   −H       343.19148              343.19193            1.3         0.4           14.63               73637
  Thiamphenicol     355.00479   −H       354.00432              354.00499            1.5         1.5           2.67                75336
  Triclocarban      313.97806   −H       312.97124              312.97111            −0.4        −0.4          15.63               48525
  Triclosan         287.95117   −H       286.90985              286.91012            1           1             16.57               71225
  Warfarin          308.10486   −H       307.10362              307.10348            −0.4        −0.4          10.78               79325

RT: retention time.
